Drug recall · June 17, 2026
GSMS Incorporated recall
Why: Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett, Inc., Seymour, IN 47274, Packaged by GSMS Incorporated, Camarillo, CA 93012. NDC 51407-268-90.
- Lots / codes
Lots: GS065128, GS065844, GS066695, GS067432, GS067993, expires: 01/31/2027.
- Quantity
- 2,961 bottles
- Company
- Golden State Medical Supply Inc., Camarillo, CA
- Distribution
- Within the U.S Market.
- Initiated
- May 29, 2026 · Voluntary: Firm initiated
- Classified
- June 11, 2026
- Reported
- June 17, 2026
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Niacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.